SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-22-024479
Filing Date
2022-11-10
Accepted
2022-11-10 16:14:46
Documents
13
Period of Report
2022-11-10
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K sprb-20221110.htm   iXBRL 8-K 64795
2 EX-99.1 sprb-ex99_1.htm EX-99.1 322256
  Complete submission text file 0000950170-22-024479.txt   529141

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT sprb-20221110_pre.xml EX-101.PRE 11520
4 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT sprb-20221110.xsd EX-101.SCH 2501
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT sprb-20221110_lab.xml EX-101.LAB 18527
7 EXTRACTED XBRL INSTANCE DOCUMENT sprb-20221110_htm.xml XML 4899
Mailing Address 2001 JUNIPERO SERRA BLVD., SUITE 640 DALY CITY CA 94104
Business Address 2001 JUNIPERO SERRA BLVD., SUITE 640 DALY CITY CA 94104 (415) 294-1687
SPRUCE BIOSCIENCES, INC. (Filer) CIK: 0001683553 (see all company filings)

IRS No.: 812154263 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39594 | Film No.: 221377353
SIC: 2834 Pharmaceutical Preparations